ROME Therapeutics
Heike Keilhack is an accomplished scientific leader with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Chief Scientific Officer at both ROME Therapeutics and Ribon Therapeutics, Heike has held multiple senior roles including Senior Vice President and Vice President of Biological Sciences. Previous positions include Senior Director and Director at Epizyme, Research Fellow at Merck, and Principal Investigator at Serono Research Institute. Heike Keilhack earned a Dipl. Biochem. degree in Biochemistry from The Martin Luther University of Halle-Wittenberg between 1991 and 1996.
This person is not in any teams
ROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.”